This article provides a detailed exploration of Pharmacokinetic/Pharmacodynamic (PK/PD) modeling as a cornerstone of modern oncology drug development and personalized treatment.
This article comprehensively examines the role of microRNAs (miRNAs) as biomarkers in PCR-based cancer diagnostics for research and drug development professionals.
This article provides a comprehensive overview of digital PCR (dPCR) and its transformative role in detecting rare alleles for oncology research and diagnostics.
This article provides a systematic review of digital PCR (dPCR) as a robust methodology for genotyping validation against the traditional gold standard of tissue biopsy.
The analysis of circulating tumor DNA (ctDNA) using digital PCR (dPCR) is transforming cancer management through non-invasive monitoring of minimal residual disease and treatment response.
The choice between spin column and magnetic bead-based methods is critical for efficient circulating tumor DNA (ctDNA) extraction, directly impacting the sensitivity and reliability of downstream liquid biopsy applications.
This article provides a comprehensive analysis of two principal digital PCR technologies: nanoplate-based and droplet-based dPCR.
This article provides a comprehensive resource for researchers and drug development professionals on determining the Limit of Quantification (LOQ) for circulating tumor DNA (ctDNA) using digital PCR (dPCR).
This article provides a comprehensive analysis of the correlation between different digital PCR (dPCR) platforms for copy number quantification, a critical task in biomedical research and drug development.
This article provides a comprehensive framework for researchers, scientists, and drug development professionals seeking to validate digital PCR (dPCR) assays for clinical applications.